 |
인쇄하기
취소
|
Revanex and Zydenar awarded for New Drug Development Prize.
The Korean Drug Research Association nominated Revanex of Yuhan and Zydenar of Dong-A as the 7th Korea New Drug Development Award in the general meeting on Feb. 23.
[First APA new drug: Revanex]
Revanex developed by Yuhan is the first APA drug, a gastric acid pump antagonist, in the world, for the treatment of peptic ulcer.
Current APA candidated drugs under development in the world i...
[First APA new drug: Revanex]
Revanex developed by Yuhan is the first APA drug, a gastric acid pump antagonist, in the world, for the treatment of peptic ulcer.
Current APA candidated drugs under development in the world i...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.